Full Title
Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT) (AREN2231) (CIRB)Purpose
Wilms tumor the most common type of kidney cancer in children. Favorable tissue (histology) Wilms tumors (FHWT) are the most common subtype.
Large clinical trials have led to the development of treatments that are likely to cure most children with FHWT. However, in some children, the cancer comes back (relapses), and some patients do not survive. Researchers have identified features of FHWT that predict a higher or lower chance of the cancer coming back after treatment.
In this study, researchers are assessing the use of risk factors to determine the best treatment for children with FHWT. They want to see how the results of tumor tissue tests, biological tests, imaging exams, and response to therapy may improve FHWT treatment.
Who Can Join
To join this study, there are a few conditions. You or your child must:
- Be newly diagnosed stage 1-4 FHWT.
- Be under age 30.
Contact
For more information about this study or to see if you or your child can join, please call 833-MSK-KIDS.